Pfizer Inc. (PFE)
NYSE: PFE · Real-Time Price · USD
24.89
-0.05 (-0.20%)
Nov 21, 2024, 12:03 PM EST - Market open
Pfizer Revenue
Pfizer had revenue of $17.70B in the quarter ending September 29, 2024, with 31.20% growth. This brings the company's revenue in the last twelve months to $59.38B, down -14.29% year-over-year. In the year 2023, Pfizer had annual revenue of $58.50B, down -41.70%.
Revenue (ttm)
$59.38B
Revenue Growth
-14.29%
P/S Ratio
2.38
Revenue / Employee
$674,716
Employees
88,000
Market Cap
141.05B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 58.50B | -41.83B | -41.70% |
Dec 31, 2022 | 100.33B | 19.04B | 23.43% |
Dec 31, 2021 | 81.29B | 39.64B | 95.16% |
Dec 31, 2020 | 41.65B | 746.00M | 1.82% |
Dec 31, 2019 | 40.91B | 80.00M | 0.20% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sanofi | 54.03B |
Bristol-Myers Squibb Company | 47.44B |
Thermo Fisher | 42.37B |
Medtronic | 32.58B |
Amgen | 32.53B |
Danaher | 23.74B |
Stryker | 21.97B |
Boston Scientific | 15.91B |
PFE News
- 2 hours ago - Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 5% Dividend Yields - Benzinga
- 8 hours ago - Zai Lab and Pfizer Announce Strategic Collaboration on the Novel Antibacterial Drug XACDURO® (Sulbactam-Durlobactam) - Business Wire
- 1 day ago - Pfizer names oncology chief and company veteran Boshoff as chief scientific officer - Market Watch
- 1 day ago - Pfizer Announces New Chief Scientific Officer and President, Research & Development - Business Wire
- 1 day ago - Pfizer names Chris Boshoff as new R&D chief, WSJ reports - Reuters
- 1 day ago - Pfizer Names New R&D Chief - WSJ
- 1 day ago - European Commission Approves Pfizer's HYMPAVZI™ (marstacimab) for the Treatment of Adults and Adolescents with Severe Hemophilia A or B Without Inhibitors - Business Wire
- 1 day ago - If I Could Only Buy 2 High Dividend Yield Companies In November 2024: Both Yield Above 6% - Seeking Alpha